Aquestive Therapeutics Inc. (AQST) Tops Q1 EPS by 6c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.07), $0.06 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $10.9 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Active options: META PLTR META SMCI MU SOFI GOOG NOK MSTR AVGO AMD HOOD
• Proshares Ultra SpaceX (SPCF) call put ratio 1.7 calls to 1 put with a focus on January 42 calls as share price down 21%